American Well Corp: directors' dealings · United States · SEC (Form 4)

About American Well Corp

American Well Corporation, which operates under the Amwell brand, is a US-listed digital health company traded on the NYSE under the ticker AMWL in the United States. The company was incorporated in Delaware in June 2006 and is headquartered in Boston, Massachusetts. Amwell’s core identity is that of an enterprise telehealth platform provider: it builds software and workflow infrastructure that allows health plans, hospitals, delivery networks, employers, retailers, and public-sector organizations to deliver virtual care at scale. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1393584/000095017025019024/amwl-20241231.htm?utm_source=openai)) From a business-model perspective, Amwell primarily monetizes a SaaS-based, technology-enabled care platform integrated into client workflows. Its solutions span a broad range of use cases, including urgent care, specialty care, behavioral health, chronic care, retail health, school-based care, and home-based care. The company’s offering combines live video visits, care coordination, administrative tools, and clinical-data integration; historically, it also marketed telehealth kiosks and related peripherals. For investors, the important distinction is that Amwell is not simply a consumer telemedicine app provider. It is positioned as an enterprise digital-care infrastructure vendor embedded in large healthcare ecosystems. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1393584/000095017025019024/amwl-20241231.htm?utm_source=openai)) In competitive terms, Amwell operates in a crowded telehealth market where pricing pressure, post-pandemic normalization of demand, and the need for deep workflow integration have become central. Its competitive advantages are tied to enterprise relationships, payer and provider distribution, and the ability to operate white-labeled solutions for large clients. The company has emphasized national-scale partnerships and a diversified client base, which supports its relevance in a market that remains highly fragmented and technically demanding. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001393584/000095017025103029/amwl-ex99_1.htm?utm_source=openai)) Recent developments are important for assessing the stock. In early 2026, Amwell extended its relationship with Elevance Health through a renewed agreement under which it operates a white-labeled digital care delivery platform branded LiveHealth Online. In May 2026, the company reported first-quarter 2026 results via an SEC filing. Also, a May 6, 2026 filing disclosed that cofounder Roy Schoenberg resigned from the board effective immediately, marking a noteworthy governance change. Taken together, these updates suggest ongoing commercial continuity, but also an evolving leadership backdrop as execution and profitability remain key investor focus areas. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1393584/000119312526007807/amwl-20260105.htm?utm_source=openai))